Used in organic synthesis as a key intermediate for pharmaceuticals, particularly in the development of protease inhibitors and other bioactive molecules. Its boronic acid functional group enables reversible interactions with diols and hydroxyl groups, making it valuable in sensor design and targeted drug delivery systems. Commonly employed in Suzuki-Miyaura cross-coupling reactions to construct biaryl frameworks found in active pharmaceutical ingredients. Also applied in the creation of boron-containing compounds for use in medical imaging and cancer therapy research.